“Supply chain issues and the dominance of a few pharmaceutical companies ... Insulin production is dominated by the US’s Eli ...

The word “exceptional” certainly applies to Lenovo. I’ve not seen a company that does a better job of agile planning across ...

The company is establishing a North Carolina factory for cold medicine as postpandemic pharma demand has grown more ...

The Act curbs US-China biotech collaborations, spurring opportunities for emerging markets in pharma supply chains.

The short answer is no. For advertisers using header bidding, implementing SPO is a must since this model increases the ...